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Abstract
We report the case of a 9-year-old girl admitted with fever, headache, and a cerebrospinal fluid lymphocytic pleocytosis. Poly-
merase chain reaction was positive for human herpes virus 6. She subsequently developed ataxia and bilateral loss of vision.
Magnetic resonance imaging (MRI) showed bilateral optic nerve lesions with extension to optic chiasm and a short-segment
myelitis. Serologic studies were positive for Borrelia burgdorferi IgM. Anti–aquaporin 4 antibody was negative and anti–myelin
oligodendrocyte glycoprotein antibody (MOG) positive. After intravenous methylprednisolone, ceftriaxone, and intravenous
immunoglobulin, her vision slowly recovered. The patient was discharged with only mild visual acuity loss, 1 month after
admission. Brain MRI was repeated later and was normal and MOG assay became negative. In our view, this patient suffered from a
postinfectious, anti-MOG–mediated, spinal cord and optic nerve demyelination.
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Borrelia burgdorferi infection is associated with neurologic
manifestations in up to 15% of cases.1 Optic neuritis related
with Lyme borreliosis has been reported infrequently and there
is uncertainty about the validity of the diagnosis in many
cases.2 Neurologic manifestations associated with human
herpes virus 6 (HHV6) infection are usually febrile seizures
in infants and encephalitis in immunosuppressed patients.3
Optic neuritis may have multiple causes, including infection
and several autoimmune diseases, such as multiple sclerosis,
acute disseminated encephalomyelitis, or neuromyelitis optica
spectrum disorders.
We describe a case of one female adolescent with anti-
myelin oligodendrocyte glycoprotein (MOG)–positive optic
neuritis and myelitis. She had a positive polymerase chain
reaction for HHV6 in cerebrospinal fluid and positive
enzyme-linked immunosorbent assay and Western blot for Bor-
relia burgdorferi in serum. We propose that our case expands
the spectrum of the association between infection and immune-
mediated MOG demyelination.
Case Report
A previously healthy 9-year-old girl of African descent living
in the Azores Islands was admitted to her local hospital with a
6-day history of a febrile illness, headache, and somnolence,
previously treated with amoxicillin-clavulanic acid without
resolution of symptoms. She had no history of recent travel.
Her white blood cell count was 16340/mL (80% neutrophils)
and c-reactive protein 0.88 mg/dL. Cerebrospinal fluid exam-
ination revealed a cell count of 95 cells/mL, with lymphocytic
predominance and elevated protein (66 mg/dL). Polymerase
chain reaction in the cerebrospinal fluid was positive for HHV6
and negative for Borrelia burgdorferi, and no serologic tests
were performed regarding HHV6. Four days later, she pre-
sented with gait imbalance, abdominal pain, and dysuria. Neu-
rologic examination was positive for gait ataxia with a positive
Romberg sign. She underwent treatment with a 21-day course
of ganciclovir (10 mg/kg/d) and was discharged on the 26th day
after admission with a normal physical examination. Brain
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magnetic resonance imaging (MRI) was normal. She was read-
mitted 11 days later with acute, painless, and bilateral but
asymmetric reduction of visual acuity.
The patient was then referred to our hospital for further
investigation. Visual acuity was severely impaired (visual
acuity 20/200 right eye, 20/100 left eye); a left-sided afferent
pupillary defect was present and there was bilateral optic disc
edema and ataxia. Considering that the present symptoms and
signs were delayed more than 1 month after the early febrile
disease, we admitted that an inflammatory mechanism could
underlie this clinical presentation and began treatment with
intravenous methylprednisolone (30 mg/kg/d for 5 days) with
a progressive but slow recovery of vision.
Brain and spinal cord MRI showed a T2 and T2 fluid-
attenuated inversion recovery hypersignal involving the poster-
ior optic nerves and optic chiasm, optic tracts, lateral geniculate
nuclei, and 3 small lesions in the posterior columns of the
dorsal spinal cord at T2, T4-T5, and T6 levels (Figure 1). There
was no contrast enhancement.
Visual evoked potentials showed P100 waves with reduced
amplitude (pattern VEPs: P100 amplitude 4.5 mV right eye, 2.7
mV left eye) and prolonged latency (pattern VEPs: P100 latency
154 ms right eye, 196 ms left eye).
Routine blood testing revealed a white blood cell count of
14 800/mL (neutrophils 87%) and a gamma-glutamyl transfer-
ase of 44 U/L. Immunologic workup was normal for ANA,
dsDNA, ANCA, SSA, SSB, anticardiolipin antibodies, and
angiotensin-converting enzyme and complement levels.
Borrelia burgdorferi IgM antibodies were positive with
enzyme-linked immunosorbent assay in 2 consecutive samples,
and the diagnosis of Lyme borreliosis was confirmed with
immunoblot testing. Serologic tests were negative for HIV,
Venereal Disease Research Laboratory, cytomegalovirus,
Epstein Barr virus, Mycoplasma pneumoniae, Chlamydia pneu-
moniae, Toxoplasma gondii, Bartonella, Coxiella burnetii, ade-
novirus, and influenza A/B antibodies.
A lumbar puncture was performed, which revealed a
cerebrospinal fluid cell count of 8 cells/mL, lymphocytes,
with normal protein and glucose, and no oligoclonal bands.
Viral polymerase chain reaction studies for enterovirus,
herpes simplex, varicella zoster, herpes hominis, cytomega-
lovirus, and Epstein Barr virus were negative. Polymerase
chain reaction for Borrelia burgdorferi was negative. Cul-
tures for fungi and Mycobacterium tuberculosis were
negative.
Indirect immunofluorescence assays using transfected full-
length MOG and Aquaporin-4 (AQP4)–expressing cells were
performed, which revealed positive anti-MOG antibodies (titer
1:32) and negative anti-AQP4 antibodies (blood samples for
these studies were collected before treatment).
Considering the clinical, laboratory, and imaging findings, a
diagnosis of autoimmune optic neuritis and myelitis was
considered.
The patient was treated with a 21-day course of ceftriaxone
(4 g daily) and a tapering dose of oral prednisolone. Because of
the severe visual loss at onset and the relative delay in recovery,
Figure 1. Fluid-attenuated inversion recovery T2 hypersignal and edema in the optic nerves and optic chiasm (A), optic tracts and lateral
geniculate bodies (B) and (C), and in the dorsal spinal cord (D and E).
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intravenous immunoglobulin was administered 14 days after
methylprednisolone.
She was discharged with only mild visual loss 1 month after
admission and was observed subsequently for 8 months in out-
patient visits remaining asymptomatic and with a normal neu-
rologic examination. Brain MRI was repeated 6 months after
discharge and was normal. MOG assay was also repeated and
became negative.
Discussion
We describe one patient with bilateral optic neuritis and mye-
litis following Lyme borreliosis who developed anti-MOG
antibodies.
Brain MRI was performed in the second week of illness and
in the sixth week. We believe that the images represent the
disease evolution appropriately. The first MRI was normal and
the second had no lesion outside the visual pathways and the
spinal cord. We considered therefore that the diagnosis of acute
disseminated encephalomyelitis without specific brain par-
enchymal lesions would be inappropriate and optic neuritis
would not be associated with a small (not longitudinally exten-
sive) but definite spinal cord lesion, her clinical picture being
more close to neuromyelitis optica spectrum disorders.
MOG positivity is not infrequent in acute disseminated
encephalomyelitis,4 in pediatric optic neuritis,5 and can be
found in some cases of AQP4-seronegative neuromyelitis
optica spectrum disorders.6,7 In MOG-positive neuromyelitis
optica spectrum disorders compared with AQP4-positive dis-
ease, the risk for incomplete recovery and for relapse appears to
be lower, as apparently occurred in our case. Monophasic
MOG-positive disease has also been described6,7 and is some-
times associated with disappearance of anti-MOG antibodies.
Primary infection with HHV6 occurs in infancy and can be
associated with febrile seizures. HHV6 may remain latent in
monocytes and macrophages so that a positive polymerase
chain reaction on cerebrospinal fluid examination is not to be
interpreted as active infection without additional investigation
(viral load, serum IgG).3 Immune suppression may give rise to
HHV6 encephalitis and myelitis, and rare cases of encephalitis
in the immunocompetent host were reported.4 Optic neuritis
has been reported with HHV6 infection only twice.8,9 On clin-
ical grounds, our patient had no evidence of immunosuppres-
sion, and so positivity for HHV6 in her first cerebrospinal fluid
study could have resulted from viral latency after early child-
hood infection. However, we cannot without additional inves-
tigations (viral load, IgG antibodies) definitely confirm or
exclude active HHV6 infection.
Our patient lives in an area endemic for Lyme borreliosis,
had fever and headache, and cerebrospinal fluid lymphocytic
pleocytosis. Samples of serum and cerebrospinal fluid were
tested with enzyme-linked immunosorbent assay for Borrelia
burgdorferi and were found to be IgM positive, as confirmed
with Western blot (virtually 100% specific for early Lyme
borreliosis).10 Early treatment with ceftriaxone may explain
her early IgM positivity without subsequent IgG response.10
The evolution of clinical signs and symptoms, the MRI
findings, and MOG positivity suggest that Borrelia infection
may have triggered MOG-positive bilateral optic neuritis and
myelitis.
In some animal models, immunization with MOG causes
features of experimental autoimmune encephalitis with domi-
nant optic nerve and spinal cord involvement. Thereafter, an
association between optic neuritis and MOG antibodies was
proposed. Although there is insufficient evidence, some studies
suggest that anti-MOG antibodies might be pathogenic by
inducing complement-dependent cytotoxicity,11 and this could
have been operative in our case.
Our patient was treated initially with immunotherapy
(intravenous methylprednisolone, intravenous immunoglobu-
lin) and later with ceftriaxone. Ataxia resolved promptly, and
later she recovered almost normal vision in both eyes. She
remained well for the past 8 months. MOG positivity was
present only during the active phase of her disease (8 months
later, MOG was negative). We decided therefore to withdraw
prednisolone over the course of several months, watch care-
fully the patient’s ophthalmologic and neurologic evolution,
and repeat MRI and optical coherence tomography at regular
intervals.
As our period of follow-up is short, we cannot admit with
certainty that a relapse will not occur in the future.
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